RAS Inhibitors

• Cardiovascular Diseases

Antihypertensive Drugs Linked to Better Liver Outcomes in MASLD

In an international multicenter cohort of 4,302 individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) and high blood pressure, renin–angiotensin…